Brief: Cara Therapeutics Q3 Revenue USD 4.9 Million Vs. IBES Estimate USD 9.95 Million
13/11/2023 21:01
Nov 13 (Reuters) - Cara Therapeutics Q3 net income USD -28 million
Recent news on Tvardi Therapeutics
See all newsTvardi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tvardi Therapeutics Q2 net loss slightly lower estimates
Brief: Tvardi Therapeutics Inc Q2 Net Income USD -6.5 Million Vs. IBES Estimate USD -6.54 Million
Tvardi Therapeutics, Inc. expected to post a loss of 70 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:50 PM